134 related articles for article (PubMed ID: 1314464)
1. Antibody response to human papillomavirus (HPV) type 11 in children with juvenile-onset recurrent respiratory papillomatosis (RRP).
Bonnez W; Kashima HK; Leventhal B; Mounts P; Rose RC; Reichman RC; Shah KV
Virology; 1992 May; 188(1):384-7. PubMed ID: 1314464
[TBL] [Abstract][Full Text] [Related]
2. Detection of anti-HPV11-L1 antibodies in immune sera from patients suffering from recurrent respiratory papillomatosis using ELISA.
Durzyńska J; Błazejewska P; Szydłowski J; Goździcka-Józefiak A
Viral Immunol; 2010 Aug; 23(4):415-23. PubMed ID: 20712486
[TBL] [Abstract][Full Text] [Related]
3. Use of human papillomavirus type 11 virions in an ELISA to detect specific antibodies in humans with condylomata acuminata.
Bonnez W; Da Rin C; Rose RC; Reichman RC
J Gen Virol; 1991 Jun; 72 ( Pt 6)():1343-7. PubMed ID: 1646276
[TBL] [Abstract][Full Text] [Related]
4. Human papillomatosis genotyping and severity in patients with recurrent respiratory papillomatosis.
Intakorn P; Sonsuwan N
J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S136-41. PubMed ID: 25391185
[TBL] [Abstract][Full Text] [Related]
5. Antibody response to a synthetic peptide derived from the human papillomavirus type 6/11 L2 protein in recurrent respiratory papillomatosis: correlation between Southern blot hybridization, polymerase chain reaction, and serology.
Tachezy R; Hamsikova E; Valvoda J; Van Ranst M; Betka J; Burk RD; Vonka V
J Med Virol; 1994 Jan; 42(1):52-9. PubMed ID: 8308521
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of antibodies against human papillomavirus type-11 E6 and L2 proteins in patients with recurrent respiratory papillomatosis.
Sameshima A; Fujiyoshi T; Pholampaisathit S; Ushikai M; Kono M; Antarasena S; Fukuda K; Furuta S; Sonoda S; Ohyama M
Auris Nasus Larynx; 1997 Apr; 24(2):185-91. PubMed ID: 9134142
[TBL] [Abstract][Full Text] [Related]
7. HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis.
Gelder CM; Williams OM; Hart KW; Wall S; Williams G; Ingrams D; Bull P; Bunce M; Welsh K; Marshall SE; Borysiewicz L
J Virol; 2003 Feb; 77(3):1927-39. PubMed ID: 12525627
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe.
Matinhira N; Soko ND; Bandason T; Jenson RG; Dzongodza T; von Buchwald C; Chidziva C
Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():147-152. PubMed ID: 30554686
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera.
Rose RC; Reichman RC; Bonnez W
J Gen Virol; 1994 Aug; 75 ( Pt 8)():2075-9. PubMed ID: 8046412
[TBL] [Abstract][Full Text] [Related]
10. Laryngopharyngeal reflux and herpes simplex virus type 2 are possible risk factors for adult-onset recurrent respiratory papillomatosis (prospective case-control study).
Formánek M; Jančatová D; Komínek P; Matoušek P; Zeleník K
Clin Otolaryngol; 2017 Jun; 42(3):597-601. PubMed ID: 27759910
[TBL] [Abstract][Full Text] [Related]
11. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis.
Kashima HK; Shah F; Lyles A; Glackin R; Muhammad N; Turner L; Van Zandt S; Whitt S; Shah K
Laryngoscope; 1992 Jan; 102(1):9-13. PubMed ID: 1309932
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the humoral immune response to genital papillomaviruses.
Galloway DA; Jenison SA
Mol Biol Med; 1990 Feb; 7(1):59-72. PubMed ID: 2157937
[TBL] [Abstract][Full Text] [Related]
13. Incidence of antibodies to human papillomavirus type 1 in patients with cutaneous and mucosal papillomas.
Viac J; Chomel JJ; Chardonnet Y; Aymard M
J Med Virol; 1990 Sep; 32(1):18-21. PubMed ID: 2173734
[TBL] [Abstract][Full Text] [Related]
14. Identification of HPV DNA in patients with juvenile-onset recurrent respiratory papillomatosis using SYBR Green real-time PCR.
Draganov P; Todorov S; Todorov I; Karchev T; Kalvatchev Z
Int J Pediatr Otorhinolaryngol; 2006 Mar; 70(3):469-73. PubMed ID: 16137771
[TBL] [Abstract][Full Text] [Related]
15. Evolution of the antibody response to human papillomavirus type 11 (HPV-11) in patients with condyloma acuminatum according to treatment response.
Bonnez W; Da Rin C; Rose RC; Tyring SK; Reichman RC
J Med Virol; 1993 Apr; 39(4):340-4. PubMed ID: 8388030
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal measures of human papillomavirus 6 and 11 viral loads and antibody response in children with recurrent respiratory papillomatosis.
Maloney EM; Unger ER; Tucker RA; Swan D; Karem K; Todd NW; Reeves WC
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):711-5. PubMed ID: 16847177
[TBL] [Abstract][Full Text] [Related]
17. Type-specific antiviral antibodies to genital human papillomavirus types in mothers and newborns.
Heim K; Hudelist G; Geier A; Szedenik H; Christensen ND; Concin N; Bergant A; Volgger B; Czerwenka K; Höpfl R
Reprod Sci; 2007 Dec; 14(8):806-14. PubMed ID: 18089599
[TBL] [Abstract][Full Text] [Related]
18. Human papilloma virus (HPV)-associated gynecological alteration in mothers of children with recurrent respiratory papillomatosis during long-term observation.
Gerein V; Schmandt S; Babkina N; Barysik N; Coerdt W; Pfister H
Cancer Detect Prev; 2007; 31(4):276-81. PubMed ID: 17935912
[TBL] [Abstract][Full Text] [Related]
19. In RRP, serologic response to HPV is frequently absent and slow to develop.
Buchinsky FJ; Ruszkay N; Valentino W; Derkay CS; McClay JE; Bastian RW; Myer CM; Lollar KW; Guris D
PLoS One; 2020; 15(3):e0230106. PubMed ID: 32160246
[TBL] [Abstract][Full Text] [Related]
20. Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer.
Combita AL; Bravo MM; Touzé A; Orozco O; Coursaget P
Int J Cancer; 2002 Feb; 97(6):796-803. PubMed ID: 11857357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
